Review article · 2025
Natural product-derived compounds in clinical trials and drug approvals
Natural Product Reports, 43(1), 20–88 · Published 9 September 2025 · DOI 10.1039/d5np00031a
In brief
“Natural product-derived compounds in clinical trials and drug approvals” is a 2025 review article by Mark S. Butler and 3 co-authors, published in Natural Product Reports. OpenAlex counts 92 citations as of 15 November 2026, which puts it in the top 1% of works published in 2025 by citations. The publisher's version is not open access, and OpenAlex records no free legal copy.
- Citations
- 92
- Most cited in
- 2026 (81)
- Field-weighted impact
- 6.42
- References
- 631
- Authors
- 4
Abstract
, 1612Natural products (NPs) have long been foundational in medicine, from ancient herbal remedies to the discovery of transformative drugs like morphine and quinine. The mid-20th century marked a 'golden age' for antibiotic discovery from natural sources, which then expanded into other therapeutic areas. However, by the late 20th century, other technological advances had shifted… Read the full abstract at the publisher.
Excerpt. This paper is not open access.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Butler, M. S., Capon, R. J., Blaskovich, M. A. T., & Henderson, I. R. (2025). Natural product-derived compounds in clinical trials and drug approvals. Natural Product Reports, 43(1), 20–88. https://doi.org/10.1039/d5np00031a
MLA 9
Butler, Mark S., et al. “Natural product-derived compounds in clinical trials and drug approvals.” Natural Product Reports, vol. 43, no. 1, 2025, pp. 20–88. https://doi.org/10.1039/d5np00031a.
Chicago
Butler, Mark S., Robert J. Capon, Mark A. T. Blaskovich, and Ian R. Henderson. 2025. “Natural product-derived compounds in clinical trials and drug approvals.” Natural Product Reports 43 (1): 20–88. https://doi.org/10.1039/d5np00031a.
Harvard
Butler, M. S. et al. (2025) ‘Natural product-derived compounds in clinical trials and drug approvals’, Natural Product Reports, 43(1), pp. 20–88. doi:10.1039/d5np00031a.
IEEE
M. S. Butler, R. J. Capon, M. A. T. Blaskovich, and I. R. Henderson, “Natural product-derived compounds in clinical trials and drug approvals,” Natural Product Reports, vol. 43, no. 1, pp. 20–88, 2025, doi: 10.1039/d5np00031a.
BibTeX
@article{butler2025natural,
title = {{Natural product-derived compounds in clinical trials and drug approvals}},
author = {Butler, Mark S. and Capon, Robert J. and Blaskovich, Mark A. T. and Henderson, Ian R.},
journal = {Natural Product Reports},
year = {2025},
volume = {43},
number = {1},
pages = {20--88},
doi = {10.1039/d5np00031a},
url = {https://doi.org/10.1039/d5np00031a}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Life Sciences › Immunology and Microbiology › Applied Microbiology and Biotechnology › Microbial Natural Products and Biosynthesis
- natural products
- natural product-derived drugs
- drug approval
- clinical trial candidates
- new chemical entities
- antibody-drug conjugates
- pharmacophore
- bioassay-guided isolation
Work with this paper
Most-cited papers in Immunology and Microbiology
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Ulrich K. Laemmli · Nature · 1970 · 249,784 citations
- Atherosclerosis — An Inflammatory DiseaseRussell Ross · New England Journal of Medicine · 1999 · 21,957 citations
- Continuous cultures of fused cells secreting antibody of predefined specificityGeorges Köhler, César Milstein · Nature · 1975 · 17,450 citations
- Inflammation and cancerLisa M. Coussens, Zena Werb · Nature · 2002 · 15,462 citations
- Dendritic cells and the control of immunityJacques Banchereau, Ralph M. Steinman · Nature · 1998 · 14,526 citations
Questions about this paper
How do I cite this paper in APA style?
Butler, M. S., Capon, R. J., Blaskovich, M. A. T., & Henderson, I. R. (2025). Natural product-derived compounds in clinical trials and drug approvals. Natural Product Reports, 43(1), 20–88. https://doi.org/10.1039/d5np00031a
How many times has this paper been cited?
92 times, according to OpenAlex on 15 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.
Who wrote this paper?
Mark S. Butler, Robert J. Capon, Mark A. T. Blaskovich, Ian R. Henderson.
What is the DOI of this paper?
10.1039/d5np00031a. The permanent link is https://doi.org/10.1039/d5np00031a.
Bibliographic data from OpenAlex (CC0), last checked 15 November 2026. ResearchGuru does not host this paper; the links go to the publisher or the repository that does.